“Genotype-Related Efficacy and Adverse Effects of Selective Serotonin Reuptake Inhibitors in Patients With Major Depressive Disorder”. Precision Medicine Communications 2, no. 1 (June 30, 2022): 27–42. Accessed May 8, 2026. https://rootspress.org/journals/index.php/PMC/article/view/44.